Heart failure related cardiotoxicity in breast cancer survivors: a scoping review

Cardiooncology. 2025 Dec 29. doi: 10.1186/s40959-025-00434-2. Online ahead of print.ABSTRACTBACKGROUND: Breast cancer is the most common malignancy among women globally and the second most frequently diagnosed cancer overall, with 2.3 million new cases reported in 2022. While advances in therapy hav

P Pinyadapat Vacharanukrauh

Uridine-Cytidine Kinase 2 (UCK2)/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21/Smurf2/Smad3 pathway after myocardial infarction

Mol Biomed. 2025 Dec 29;6(1):151. doi: 10.1186/s43556-025-00397-x.ABSTRACTCardiac fibrosis following myocardial infarction (MI) is a pivotal driver of ventricular dysfunction and heart failure, yet the molecular checkpoints orchestrating the persistent activation of cardiac fibroblasts remain incomp

X Xiao Zhou

Leadless Devices: the Future of Pacing

Curr Cardiol Rep. 2025 Dec 29;28(1):5. doi: 10.1007/s11886-025-02331-7.ABSTRACTPURPOSE OF REVIEW: Leadless pacemakers (LPMs) are an established alternative to transvenous pacing systems for the treatment of bradyarrhythmias. This review outlines the evolution of LPMs, summarizes available safety and

B Benjamin W Furman

Tirofiban for Preventing Early Neurological Deterioration in Acute Ischemic Stroke Within 48 Hours of Onset: Evidence From a Dual-Method Analysis Using Propensity Score Matching and Multivariable Regression

CNS Neurosci Ther. 2025 Dec;31(12):e70718. doi: 10.1002/cns.70718.ABSTRACTBACKGROUND: Previous studies have indicated the potential benefits of tirofiban in preventing early neurological deterioration (END) in acute ischemic stroke (AIS) within 24 h of symptom onset. However, its efficacy and safety

Q Qianru Wen

Reprint of: Managing Medications During "Sick Days" in Patients With Diabetes, Kidney, and Cardiovascular Conditions: A Theory-informed Approach to Intervention Design and Implementation

Can J Diabetes. 2025 Nov;49 Suppl 2:27-36.e4. doi: 10.1016/j.jcjd.2025.10.172.ABSTRACTOBJECTIVES: Our aim in this work was to 1) explore barriers and enablers to patient and health-care provider (HCP) behaviours related to sick-day medication guidance (SDMG), 2) identify theory-informed strategies t

K Kaitlyn E Watson